Your browser doesn't support javascript.
loading
Zika and dengue but not chikungunya are associated with Guillain-Barré syndrome in Mexico: A case-control study.
Grijalva, Israel; Grajales-Muñiz, Concepción; González-Bonilla, César; Borja-Aburto, Victor Hugo; Paredes-Cruz, Martín; Guerrero-Cantera, José; González-Ibarra, Joaquín; Vallejos-Parás, Alfonso; Rojas-Mendoza, Teresita; Santacruz-Tinoco, Clara Esperanza; Hernández-Bautista, Porfirio; Arriaga-Nieto, Lumumba; Garza-Sagástegui, Ma Guadalupe; Vargas-Ramos, Ignacio; Sepúlveda-Núñez, Ana; Campos-Villarreal, Omar Israel; Corrales-Pérez, Roberto; Azuara-Castillo, Mallela; Sierra-González, Elsa; Meza-Medina, José Alfonso; Martínez-Miguel, Bernardo; López-Becerril, Gabriela; Ramos-Orozco, Jessica; Muñoz-Guerrero, Tomás; Gutiérrez-Lozano, María Soledad; Cervantes-Ocampo, Arlette Areli.
Afiliação
  • Grijalva I; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Grajales-Muñiz C; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • González-Bonilla C; Division of Surveillance Laboratories and Epidemiological Research, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Borja-Aburto VH; Primary Health-Care Unit. Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Paredes-Cruz M; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Guerrero-Cantera J; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • González-Ibarra J; Division of Surveillance Laboratories and Epidemiological Research, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Vallejos-Parás A; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Rojas-Mendoza T; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Santacruz-Tinoco CE; Central Laboratory of Epidemiology, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Hernández-Bautista P; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Arriaga-Nieto L; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Garza-Sagástegui MG; Medical Provisions for the State Nuevo León, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
  • Vargas-Ramos I; UMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
  • Sepúlveda-Núñez A; UMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
  • Campos-Villarreal OI; UMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
  • Corrales-Pérez R; Medical Epidemiological Assistance Coordination of the State of Nuevo León, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
  • Azuara-Castillo M; Hospital General de Zona No. 33, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
  • Sierra-González E; Hospital General de Zona No. 33, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
  • Meza-Medina JA; Hospital General de Zona No. 33, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico.
  • Martínez-Miguel B; Central Laboratory of Epidemiology, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • López-Becerril G; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Ramos-Orozco J; Hospital General Regional No.1, Instituto Mexicano del Seguro Social, Tijuana, Baja California, Mexico.
  • Muñoz-Guerrero T; Hospital General Regional No.1, Instituto Mexicano del Seguro Social Orizaba, Veracruz, Mexico.
  • Gutiérrez-Lozano MS; Hospital General Regional No.1, Instituto Mexicano del Seguro Social Orizaba, Veracruz, Mexico.
  • Cervantes-Ocampo AA; Hospital General de Zona y Medicina Familiar No. 36, Instituto Mexicano del Seguro Social, Coatzacoalcos, Veracruz, Mexico.
PLoS Negl Trop Dis ; 14(12): e0008032, 2020 12.
Article em En | MEDLINE | ID: mdl-33332366
Background Zika, dengue and chikungunya viruses (ZIKV, CHIKV and DENV) are temporally associated with neurological diseases, such as Guillain-Barré syndrome (GBS). Because these three arboviruses coexist in Mexico, the frequency and severity of GBS could theoretically increase. This study aims to determine the association between these arboviruses and GBS in a Mexican population and to establish the clinical characteristics of the patients, including the severity of the infection. A case-control study was conducted (2016/07/01-2018/06/30) in Instituto Mexicano del Seguro Social (Mexican Social Security Institute) hospitals, using serum and urine samples that were collected to determine exposure to ZIKV, DENV, CHIKV by RT-qPCR and serology (IgM). For the categorical variables analysis, Pearson's χ2 or Fisher exact tests were used, and the Mann-Whitney U test for continuous variables. To determine the association of GBS and viral infection diagnosis through laboratory and symptomatology before admission, we calculated the odds ratio (OR) and 95% confidence intervals (95%CI) using a 2x2 contingency table. A p-value ≤ 0.05 was considered as significant. Ninety-seven GBS cases and 184 controls were included. The association of GBS with ZIKV acute infection (OR, 8.04; 95% CI, 0.89-73.01, p = 0.047), as well as laboratory evidence of ZIKV infection (OR, 16.45; 95% CI, 2.03-133.56; p = 0.001) or Flavivirus (ZIKV and DENV) infection (OR, 6.35; 95% CI, 1.99-20.28; p = 0.001) was observed. Cases of GBS associated with ZIKV demonstrated a greater impairment of functional status and a higher percentage of mechanical ventilation. According to laboratory results, an association between ZIKV or ZIKV and DENV infection in patients with GBS was found. Cases of GBS associated with ZIKV exhibited a more severe clinical picture. Cases with co-infection were not found.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Guillain-Barré / Dengue / Febre de Chikungunya / Infecção por Zika virus Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Mexico Idioma: En Revista: PLoS Negl Trop Dis Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2020 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Guillain-Barré / Dengue / Febre de Chikungunya / Infecção por Zika virus Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Mexico Idioma: En Revista: PLoS Negl Trop Dis Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2020 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos